- Types of Eczema
- Child Eczema
- Causes & Triggers
- Living with Eczema
- Eczema Products
- Get Involved
PRESS RELEASE One in five children with eczema will be bullied this school year due to their disease, according to the National Eczema Association San Rafael, California, September 7, 2016 – Results from a new National Eczema Association (NEA) survey of eczema parents and caregivers show that at least one in five children with eczema, including […]
What you need to know Finding a treatment that works for your eczema or atopic dermatitis (AD) symptoms can feel like an endless cycle for some people. And it’s not just about finding the right medicine, but about getting it covered by your health plan as well. It’s hard enough when your eczema is flaring; […]
By Debbie Byrnes Itching for a Cure (IFAC). It’s a feel-good day surrounded by people who respect you for your perseverance. And it’s the only walk for eczema and helps raise money for research, support, and education. This year, IFAC will take place on Sunday, October 2, in Los Angeles. When I think of all […]
… I am a woman surviving it. Who calls into work sick because of eczema? That’s what I’m sure people thought when I was consistently missing work due to lack of sleep, broken and bleeding skin, and sometimes just feeling too emotionally unstable to hold it together in the office. I was doing my best […]
Understanding AD’s impact to improve your quality of life People living with atopic dermatitis (AD), the most common and chronic form of eczema, know first-hand the burden AD has on both individuals and families. The impacts reach far beyond the serious effects of the disease symptoms such as itch, pain, and inflammation –they also include […]
Eczema affects more than 30 million people in the United States. The most common and chronic form of eczema is known as atopic dermatitis (AD). There is currently no cure for eczema or AD. To help raise awareness about the serious impact AD has on individuals and families, the National Eczema Association (NEA) has joined […]
We asked, you answered. The verdict? People living with eczema want more information and more options. This past January, many of you responded to a 6-question online survey to evaluate patient satisfaction and the role of doctors in the treatment of the most serious form of eczema, atopic dermatitis (AD). We learned that the vast majority of […]
Vice President, Advocacy and Access. Tim will be responsible for development and implementation of key advocacy initiatives that will advance NEA’s mission to improve the quality of life for individuals with eczema through research, support, and education. Tim most recently served as President of Foretop, a consulting firm that provided advocacy and business planning services […]
June 9, 2016 – On Monday, June 6, 2016 the pharmaceutical companies Regeneron and Sanofi, reported positive results for the Phase 3 the clinical trial of the new biologic drug, dupilumab, when used in conjunction with a topical corticosteroid by adults to treat moderate-to-severe atopic dermatitis (AD).
May 22, 2016 – Nathan lives in Chicago where he is a medical student. He was diagnosed with eczema at two months old and suffered from severe eczema in grade school and high school. Through treatment, great doctors and avoidance of triggers he has been under control since graduating college.